Genomind’s Chief Medical Officer, Dr. David Krause, and Vice President of Medical Affairs, Dr. Daniel Dowd, are joined by guest speakers, Dr. Jay Fawver, Dr. Peter Yellowlees, and Jacob Harper, JD. They discuss increasingly relevant topics such as how to transition to telepsychiatry in the age of COVID-19, insights into the rapidly evolving regulatory landscape, and how to continue using Genomind’s pharmacogenetic tests from home.
Filmed April 13th, 2020
Are You Ready to Upgrade Your Practice with Genomind?
Genomind’s pharmacogenetic testing is the most advanced and comprehensive mental health pharmacogenetic test available. Get access to 24 genes related to mental health, 130+ medications, 10+ conditions, state-of-the-art tools, and 360 degrees of support today!
